Replies to post #249127 on Biotech Values

[dewophile]

By mid year they will have RSV data and presumably better insight re Covid as pfe and Shionogi read out
If both are a bust I’m sure expenses will go way down
There also have a royalty stream that will be worth about 150M
So f everything goes south even the lawsuit there’s a path to higher share price than where we currently sit